Amedica Corporation to Host Conference Call to Discuss Recent Sale of Spine Implant Business and Transition to Biomaterials Company

SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced today that it will host a conference call with Dr. Sonny Bal, Chairman and CEO of Amedica Corporation, to discuss the recently announced sale of its spine implant business to CTL Medical and its transition to a biomaterials company.

Details related to this call are as follows:

Date: Thursday, September 13, 2018

Time: 11:00 a.m., Eastern Time

Dial-in: Toll-free 877-524-8416
International 412-902-1028

Questions: Questions will not be taken during the call. Investors may submit questions prior to the call via email to IR@amedica.com. Questions will be accepted through 10:00 p.m. Mountain time on Tuesday, September 11, 2018.

For those who are not available to listen to the call, a digital replay will be archived on the investor relations section of the Amedica website under Events & Presentations.

About Amedica Corporation

Amedica is an innovative biomaterials and OEM company that develops and commercializes silicon nitride for various biomedical applications including orthopedic, dental and arthroplasty.

Contacts:
Amedica IR
801-839-3502
IR@amedica.com

Released September 11, 2018